124
Views
6
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

The role of rifaximin therapy in patients with irritable bowel syndrome without constipation

&
Pages 461-464 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Natalya Iorio, Zubair Malik & Ron Schey. (2015) Profile of rifaximin and its potential in the treatment of irritable bowel syndrome. Clinical and Experimental Gastroenterology 8, pages 159-167.
Read now
Simona Deiana, Tommaso Gabbani, Siro Bagnoli & Vito Annese. (2015) Emerging drug for diarrhea predominant irritable bowel syndrome. Expert Opinion on Emerging Drugs 20:2, pages 247-261.
Read now
Shilan Mozaffari, Shekoufeh Nikfar & Mohammad Abdollahi. (2013) Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Metabolism & Toxicology 9:4, pages 403-421.
Read now

Articles from other publishers (3)

Jan Juřica & Radek Kroupa. (2017) Pharmacotherapy of irritable bowel syndrome. Praktické lékárenství 13:2, pages 52-59.
Crossref
Shin Fukudo, Hiroshi Kaneko, Hirotada Akiho, Masahiko Inamori, Yuka Endo, Toshikatsu Okumura, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Toshimi Chiba, Kenji Furuta, Shigeru Yamato, Tetsuo Arakawa, Yoshihide Fujiyama, Takeshi Azuma, Kazuma Fujimoto, Tetsuya Mine, Soichiro Miura, Yoshikazu Kinoshita, Kentaro Sugano & Tooru Shimosegawa. (2014) Evidence-based clinical practice guidelines for irritable bowel syndrome. Journal of Gastroenterology 50:1, pages 11-30.
Crossref
Franco Scaldaferri, Marco Pizzoferrato, Silvia Pecere, Fabrizio Forte & Antonio Gasbarrini. (2012) Bacterial Flora as a Cause or Treatment of Chronic Diarrhea. Gastroenterology Clinics of North America 41:3, pages 581-602.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.